A novel SMARCC1 BAFopathy implicates neural progenitor epigenetic dysregulation in human hydrocephalus
© The Author(s) 2023. Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For commercial re-use, please contact reprintsoup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com..
Hydrocephalus, characterized by cerebral ventriculomegaly, is the most common disorder requiring brain surgery in children. Recent studies have implicated SMARCC1, a component of the BRG1-associated factor (BAF) chromatin remodelling complex, as a candidate congenital hydrocephalus gene. However, SMARCC1 variants have not been systematically examined in a large patient cohort or conclusively linked with a human syndrome. Moreover, congenital hydrocephalus-associated SMARCC1 variants have not been functionally validated or mechanistically studied in vivo. Here, we aimed to assess the prevalence of SMARCC1 variants in an expanded patient cohort, describe associated clinical and radiographic phenotypes, and assess the impact of Smarcc1 depletion in a novel Xenopus tropicalis model of congenital hydrocephalus. To do this, we performed a genetic association study using whole-exome sequencing from a cohort consisting of 2697 total ventriculomegalic trios, including patients with neurosurgically-treated congenital hydrocephalus, that total 8091 exomes collected over 7 years (2016-23). A comparison control cohort consisted of 1798 exomes from unaffected siblings of patients with autism spectrum disorder and their unaffected parents were sourced from the Simons Simplex Collection. Enrichment and impact on protein structure were assessed in identified variants. Effects on the human fetal brain transcriptome were examined with RNA-sequencing and Smarcc1 knockdowns were generated in Xenopus and studied using optical coherence tomography imaging, in situ hybridization and immunofluorescence. SMARCC1 surpassed genome-wide significance thresholds, yielding six rare, protein-altering de novo variants localized to highly conserved residues in key functional domains. Patients exhibited hydrocephalus with aqueductal stenosis; corpus callosum abnormalities, developmental delay, and cardiac defects were also common. Xenopus knockdowns recapitulated both aqueductal stenosis and cardiac defects and were rescued by wild-type but not patient-specific variant SMARCC1. Hydrocephalic SMARCC1-variant human fetal brain and Smarcc1-variant Xenopus brain exhibited a similarly altered expression of key genes linked to midgestational neurogenesis, including the transcription factors NEUROD2 and MAB21L2. These results suggest de novo variants in SMARCC1 cause a novel human BAFopathy we term 'SMARCC1-associated developmental dysgenesis syndrome', characterized by variable presence of cerebral ventriculomegaly, aqueductal stenosis, developmental delay and a variety of structural brain or cardiac defects. These data underscore the importance of SMARCC1 and the BAF chromatin remodelling complex for human brain morphogenesis and provide evidence for a 'neural stem cell' paradigm of congenital hydrocephalus pathogenesis. These results highlight utility of trio-based whole-exome sequencing for identifying pathogenic variants in sporadic congenital structural brain disorders and suggest whole-exome sequencing may be a valuable adjunct in clinical management of congenital hydrocephalus patients.
| Errataetall: | |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:147 |
|---|---|
| Enthalten in: |
Brain : a journal of neurology - 147(2024), 4 vom: 04. Apr., Seite 1553-1570 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Singh, Amrita K [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 08.04.2024 Date Revised 15.04.2024 published: Print UpdateOf: medRxiv. 2023 Mar 20;:. - PMID 36993720 Citation Status MEDLINE |
|---|
| doi: |
10.1093/brain/awad405 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM366192035 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM366192035 | ||
| 003 | DE-627 | ||
| 005 | 20240415233043.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231227s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1093/brain/awad405 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1376.xml |
| 035 | |a (DE-627)NLM366192035 | ||
| 035 | |a (NLM)38128548 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Singh, Amrita K |e verfasserin |4 aut | |
| 245 | 1 | 2 | |a A novel SMARCC1 BAFopathy implicates neural progenitor epigenetic dysregulation in human hydrocephalus |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 08.04.2024 | ||
| 500 | |a Date Revised 15.04.2024 | ||
| 500 | |a published: Print | ||
| 500 | |a UpdateOf: medRxiv. 2023 Mar 20;:. - PMID 36993720 | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © The Author(s) 2023. Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For commercial re-use, please contact reprintsoup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com. | ||
| 520 | |a Hydrocephalus, characterized by cerebral ventriculomegaly, is the most common disorder requiring brain surgery in children. Recent studies have implicated SMARCC1, a component of the BRG1-associated factor (BAF) chromatin remodelling complex, as a candidate congenital hydrocephalus gene. However, SMARCC1 variants have not been systematically examined in a large patient cohort or conclusively linked with a human syndrome. Moreover, congenital hydrocephalus-associated SMARCC1 variants have not been functionally validated or mechanistically studied in vivo. Here, we aimed to assess the prevalence of SMARCC1 variants in an expanded patient cohort, describe associated clinical and radiographic phenotypes, and assess the impact of Smarcc1 depletion in a novel Xenopus tropicalis model of congenital hydrocephalus. To do this, we performed a genetic association study using whole-exome sequencing from a cohort consisting of 2697 total ventriculomegalic trios, including patients with neurosurgically-treated congenital hydrocephalus, that total 8091 exomes collected over 7 years (2016-23). A comparison control cohort consisted of 1798 exomes from unaffected siblings of patients with autism spectrum disorder and their unaffected parents were sourced from the Simons Simplex Collection. Enrichment and impact on protein structure were assessed in identified variants. Effects on the human fetal brain transcriptome were examined with RNA-sequencing and Smarcc1 knockdowns were generated in Xenopus and studied using optical coherence tomography imaging, in situ hybridization and immunofluorescence. SMARCC1 surpassed genome-wide significance thresholds, yielding six rare, protein-altering de novo variants localized to highly conserved residues in key functional domains. Patients exhibited hydrocephalus with aqueductal stenosis; corpus callosum abnormalities, developmental delay, and cardiac defects were also common. Xenopus knockdowns recapitulated both aqueductal stenosis and cardiac defects and were rescued by wild-type but not patient-specific variant SMARCC1. Hydrocephalic SMARCC1-variant human fetal brain and Smarcc1-variant Xenopus brain exhibited a similarly altered expression of key genes linked to midgestational neurogenesis, including the transcription factors NEUROD2 and MAB21L2. These results suggest de novo variants in SMARCC1 cause a novel human BAFopathy we term 'SMARCC1-associated developmental dysgenesis syndrome', characterized by variable presence of cerebral ventriculomegaly, aqueductal stenosis, developmental delay and a variety of structural brain or cardiac defects. These data underscore the importance of SMARCC1 and the BAF chromatin remodelling complex for human brain morphogenesis and provide evidence for a 'neural stem cell' paradigm of congenital hydrocephalus pathogenesis. These results highlight utility of trio-based whole-exome sequencing for identifying pathogenic variants in sporadic congenital structural brain disorders and suggest whole-exome sequencing may be a valuable adjunct in clinical management of congenital hydrocephalus patients | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a chromatin | |
| 650 | 4 | |a congenital | |
| 650 | 4 | |a genetics | |
| 650 | 4 | |a genomics | |
| 650 | 4 | |a neurodevelopment | |
| 650 | 4 | |a neurosurgery | |
| 650 | 7 | |a Transcription Factors |2 NLM | |
| 650 | 7 | |a SMARCC1 protein, human |2 NLM | |
| 650 | 7 | |a MAB21L2 protein, human |2 NLM | |
| 650 | 7 | |a Eye Proteins |2 NLM | |
| 650 | 7 | |a Intracellular Signaling Peptides and Proteins |2 NLM | |
| 700 | 1 | |a Allington, Garrett |e verfasserin |4 aut | |
| 700 | 1 | |a Viviano, Stephen |e verfasserin |4 aut | |
| 700 | 1 | |a McGee, Stephen |e verfasserin |4 aut | |
| 700 | 1 | |a Kiziltug, Emre |e verfasserin |4 aut | |
| 700 | 1 | |a Ma, Shaojie |e verfasserin |4 aut | |
| 700 | 1 | |a Zhao, Shujuan |e verfasserin |4 aut | |
| 700 | 1 | |a Mekbib, Kedous Y |e verfasserin |4 aut | |
| 700 | 1 | |a Shohfi, John P |e verfasserin |4 aut | |
| 700 | 1 | |a Duy, Phan Q |e verfasserin |4 aut | |
| 700 | 1 | |a DeSpenza, Tyrone |c Jr |e verfasserin |4 aut | |
| 700 | 1 | |a Furey, Charuta G |e verfasserin |4 aut | |
| 700 | 1 | |a Reeves, Benjamin C |e verfasserin |4 aut | |
| 700 | 1 | |a Smith, Hannah |e verfasserin |4 aut | |
| 700 | 1 | |a Sousa, André M M |e verfasserin |4 aut | |
| 700 | 1 | |a Cherskov, Adriana |e verfasserin |4 aut | |
| 700 | 1 | |a Allocco, August |e verfasserin |4 aut | |
| 700 | 1 | |a Nelson-Williams, Carol |e verfasserin |4 aut | |
| 700 | 1 | |a Haider, Shozeb |e verfasserin |4 aut | |
| 700 | 1 | |a Rizvi, Syed R A |e verfasserin |4 aut | |
| 700 | 1 | |a Alper, Seth L |e verfasserin |4 aut | |
| 700 | 1 | |a Sestan, Nenad |e verfasserin |4 aut | |
| 700 | 1 | |a Shimelis, Hermela |e verfasserin |4 aut | |
| 700 | 1 | |a Walsh, Lauren K |e verfasserin |4 aut | |
| 700 | 1 | |a Lifton, Richard P |e verfasserin |4 aut | |
| 700 | 1 | |a Moreno-De-Luca, Andres |e verfasserin |4 aut | |
| 700 | 1 | |a Jin, Sheng Chih |e verfasserin |4 aut | |
| 700 | 1 | |a Kruszka, Paul |e verfasserin |4 aut | |
| 700 | 1 | |a Deniz, Engin |e verfasserin |4 aut | |
| 700 | 1 | |a Kahle, Kristopher T |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Brain : a journal of neurology |d 1945 |g 147(2024), 4 vom: 04. Apr., Seite 1553-1570 |w (DE-627)NLM000126292 |x 1460-2156 |7 nnns |
| 773 | 1 | 8 | |g volume:147 |g year:2024 |g number:4 |g day:04 |g month:04 |g pages:1553-1570 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1093/brain/awad405 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 147 |j 2024 |e 4 |b 04 |c 04 |h 1553-1570 | ||